|
|
Am. J. Biomed. Sci. 2022,14(1),29-38;doi:10.5099/aj220100029 |
In-vivo Antiplasmodial Impact of Dihydroartemisinin-Piperaquine-Clindamycin
on Plasmodium berghei-Infected Mice |
Elias Adikwu1, Simeon Ajeka Igono2 and Nwakaego
Omonigho Ebong *3 |
1 Department of Pharmacology
/Toxicology, Faculty of Pharmacy, Niger Delta University, Bayelsa State,
Nigeria |
2 Department of Biology, Faculty of Natural and Applied
Sciences, Ignatius Ajuru University of Education, Rumuolumeni, Port Harcourt, Rivers State, Nigeria |
3 Department of Pharmacology, Faculty of Basic Clinical
Sciences, University of Port Harcourt, Rivers State, Nigeria |
*Corresponding
Author |
Nwakaego Omonigho Ebong |
Department of Pharmacology |
Faculty of Basic Clinical Sciences |
University of Port Harcourt, Rivers State |
Nigeria |
Email: nwakaebong@gmail.com |
Tel: +2348132321014 |
Abstract Objective: The concurrent use of antibiotics and antimalarial drugs may increase Plasmodium susceptibility. Clindamycin (C) is an antibiotic with potential antiplasmodial activity. Dihydroartemisinin-piperaquine (D-P) is an effective antimalarial drug. This study examined the antiplasmodial effect of dihydroartemisinin-piperaquine-clindamycin (D-P-C) on mice infected with Plasmodium berghei. |
Methods: Adult Swiss albino mice (25-30g) of n=6/group were used. Using the curative, suppressive and prophylactic tests, mice were infected with Plasmodium. berghei and orally treated per day with D-P (1.71/13.7mg/kg), C (10mg/kg) and D-P-C, respectively. The positive control was orally treated per day with chloroquine (CQ) (10 mg/kg) whereas the normal and the negative controls were orally treated per day with normal saline (0.2ml). |
Results: In the curative, suppressive and prophylactic tests, D-P-C decreased percentage parasitemia levels with significant difference observed at p<0.05 when compared to individual doses of C, D-P and CQ. D-P-C significantly prolonged mean survival time with difference observed at p< 0.05 when compared to individual doses of D and D-P. The anti-anemic effect of D-P-C was characterized by increased hemoglobin, red blood cells, packed cell volume and decreased white blood cells with significant difference observed at p<0.05 when compared to individual doses of C, D-P and CQ. Treatment with D-P-C eradicated liver Plasmodium. |
Conclusion: D-P-C showed
promising antiplasmodial activity. It may be used for the treatment of malaria. |
Keywords: Artemisinin, Piperaquine, Clindamycin, Plasmodium, Mice |
Download the full article (PDF)
|
Publisher | Missions and Scope | Editorial Board | Instructions for Authors |
© American Journal of Biomedical Sciences 2007-2021. All Rights Reserved. |